1Basta G,Lazzerini G,Del Turco S,et al.At least 2 distinct pathways generating reactive oxygen species mediate vascular cell adhesion molecule-1 induction by advanced glycation end products.Arterioscler Thromb Vasc Biol,2005,25 (7):1401-1407.
2Wittebole X,Coyle SM,Kumar A,et al.Expression of tumour necrosis factor receptor and Toll-like receptor 2 and 4 on peripheral blood leucocytes of human volunteers after endotoxin challenge:a comparison of flow cytometric light scatter and immunofluorescence gating.Clin Exp Immunol,2005,141(1):99-106.
3Akira S,Sato S.Toll-like receptors and their signaling mechanisms.Scand J Infect Dis,2003,35 (9):555-562.
4Salvi GE,Spets-Happonen S,Singer RE,et al.Reconstitution of hyperinflammatory prostaglandin E2 response to Porphyromonas gingivalis challenge in severe combined immunodeficient mice.J Periodontol,2005,76(1):16-21.
5Salvi GE,Beck JD,Offenbacher S.PGE2,IL-1 beta,and TNF-alpha responses in diabetics as modifiers of periodontal disease expression.Ann Periodontol,1998,3 (1):40-50.
6Kolb H,Mandrup-Poulsen T.An immune origin of type 2 diabetes?Diabetologia,2005,48(6):1038 -1050.
7Wellen KE,Hotamisligil GS.Obesity-induced inflammatory changes in adipose tissue.J Clin Invest,2003,112(12):1785-1788.
8Savage DB,Petersen KF,Shulman GI.Mechanisms of insulin resistance in humans and possible links with inflammation.Hypertension,2005,45 (5):828-833.
9Zhang L,Zalewski A,Liu Y,et al.Diabetes-induced oxidative stress and low-grade inflammation in porcine coronary arteries.Circulation,2003,108 (4):472-478.
10Lalla E,Lamster IB,Stern DM,et al.Receptor for advanced glycation end products,inflammation,and accelerated periodontal disease in diabetes:mechanisms and insights into therapeutic modalities.Ann Periodontol,2001,6(1):113-118.
